🇺🇸 FDA
Patent

US 9278116

Compositions and methods for treatment of pain

granted A61KA61K31/17A61K33/04

Quick answer

US patent 9278116 (Compositions and methods for treatment of pain) held by Princeton Biotechnology Corporation expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Princeton Biotechnology Corporation
Grant date
Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/17, A61K33/04, A61K33/38, A61K35/74